N2off, INC

Nexentis Technologies Inc. announced a $1.25 million capital raise through a registered direct offering of common stock and a concurrent private placement of warrants.

Nexentis Technologies Inc. has amended its credit facility with L.I.A. Pure Capital Ltd., increasing the total available financing to EUR 10,000,000 and modifying warrant terms.

Nexentis Technologies stockholders approved key proposals including reverse stock split authority and equity issuance.

Nexentis Technologies Inc. will implement a 1-for-7 reverse stock split effective April 7, 2026, to consolidate its outstanding common shares.

Nexentis Technologies Inc. has completed the transfer of its 98% stake in Save Foods Ltd. to Voice Assist, Inc., receiving a 19.99% equity interest in Voice Assist and entering into a services agreement.

Nexentis Technologies Inc. issued 600,000 common shares to consultants for investor relations and business development services.

Nexentis Technologies Inc. reported a net loss of $6.59 million for Q1 2026, impacted by a $6.3 million goodwill impairment charge related to its MitoCareX subsidiary, alongside strategic divestitures and ongoing development in biotechnology and renewable energy.

N2OFF, Inc. reports Q3 2025 results, highlighting strategic shifts into oncology and renewable energy, a significant MitoCareX acquisition, and ongoing capital raises amidst a going concern warning.

N2OFF, Inc. reported a significantly wider net loss in Q2 2025, driven by increased operating expenses and fair value adjustments, despite a slight revenue increase and strategic expansion into renewable energy.

N2OFF Inc. reports increased revenue for Q1 2025 driven by US client sales, alongside strategic investments in renewable energy projects and a focus on improving financial stability.

N2OFF Inc. reports a net loss for the third quarter of 2024, impacted by decreased revenues and increased operating expenses, while navigating ongoing geopolitical and financial challenges.

N2OFF Inc. reports a decrease in revenue and a net loss for the second quarter of 2024, while navigating operational challenges in Israel.

Nexentis Technologies Inc. reported a reduced net loss in 2025, driven by strategic divestitures and new ventures in oncology biotechnology and solar energy, despite ongoing operating losses and a going concern warning.

N2OFF Inc. reports its fiscal year 2024 results, detailing a net loss, strategic investments in renewable energy and nitrous oxide emission reduction, and ongoing efforts to commercialize its agri-food tech solutions.

N2OFF, Inc.'s annual report details its authorized capital stock, voting rights, and measures designed to deter hostile takeovers.

A director and 10% owner of Nexentis Technologies Inc. sold 127 shares of common stock.

N2OFF, Inc. Controller Shlomo Zakai received an award of 50,000 restricted common shares as part of an incentive plan, increasing his indirect beneficial ownership to 64,778 shares.

N2OFF, Inc.'s Chief Financial Officer, Lital Barda, was granted 50,000 restricted shares of common stock as part of the company's incentive plan.

N2OFF, Inc. Director Amitay Weiss acquired 116,286 restricted common shares, increasing his beneficial ownership to 129,144 shares.

N2OFF, Inc. CEO David Palach received a grant of 100,000 restricted common shares under the Save Foods, Inc. 2022 Share Incentive Plan.

Lital Barda, CFO of N2OFF, Inc., reports the acquisition of 300,000 restricted shares of common stock on May 12, 2025, under the company's 2022 Share Incentive Plan.

Nexentis Technologies Inc. calls a special meeting to approve a reverse stock split, a discounted equity issuance, and an expanded credit facility to maintain Nasdaq listing and fund operations.

N2OFF, Inc. announced its annual stockholder meeting to vote on director elections, a significant increase in its share incentive plan, and an advisory vote on director share grants.

N2OFF, Inc. calls a special meeting to approve the acquisition of cancer drug discovery firm MitoCareX Bio Ltd., a significant stock issuance, and a reverse stock split to maintain Nasdaq listing.

N2OFF, Inc. amended its bylaws to lower the quorum requirement for stockholder meetings to one-third ahead of its Annual Meeting on November 13, 2024.

N2OFF, Inc. is holding its annual meeting of stockholders on November 13, 2024, to vote on key proposals including the election of directors, an amendment to the share incentive plan, an increase in authorized capital, and the potential issuance of securities in non-public offerings.

N2OFF, Inc. is holding a special meeting of stockholders to vote on proposals for a reverse stock split and an increase in the number of authorized shares to maintain Nasdaq listing compliance and facilitate future financing.

Nexentis Technologies Inc. has filed an S-1 registration statement to allow selling stockholders to offer up to 2,572,874 shares of common stock.

N2OFF, Inc. reports continued significant losses and negative cash flows, raising substantial doubt about its ability to continue as a going concern, despite ongoing capital raises and strategic shifts into solar energy.

N2OFF, Inc. reports continued operating losses and substantial doubt about its ability to continue as a going concern, while pursuing strategic shifts in agri-food tech and renewable energy, and seeking significant capital through equity agreements.

N2OFF Inc. is registering for the resale of up to 53.1 million shares of common stock by selling stockholders, including shares from a recent private placement and warrants.

N2OFF, Inc. has filed a registration statement for the resale of up to 53,125,000 shares of common stock by existing stockholders, including shares issuable upon exercise of warrants.

N2OFF, Inc. has filed a registration statement for the resale of up to 53,125,000 shares of common stock by selling stockholders, following a recent private placement.

Eun Young Lee reports beneficial ownership of 47,000 shares, representing 3.23% of Nexentis Technologies Inc. common stock.

Eun Young Lee has reported a beneficial ownership of 9.38% of Nexentis Technologies Inc.'s common stock, totaling 479,524 shares.

Ciro Leonardo Pierri has filed an amended Schedule 13G, disclosing a 4.44% beneficial ownership stake in N2OFF, Inc. as a passive investor.

Alon Silberman, CEO of N2OFF's subsidiary, has reported beneficial ownership of 16.93% of the company's common stock.

SciSparc Ltd. has reported a beneficial ownership of 18.3% of N2OFF, Inc.'s common stock, holding 490,751 shares as of October 20, 2025.

Kfir Silberman and L.I.A Pure Capital Ltd. have jointly disclosed a beneficial ownership of 7.81% in N2OFF, Inc.'s common stock, including shares held directly and through exercisable warrants.